If you need to inquire about Bayer product, please contact us through the following telephone:

Hotline: 400-810-0360 (available by mobile or telephone)

We will try our best to provide you the information about Bayer products, but we can't propose any specific diagnosis and treatment suggestions for patients' conditions. If you have any discomfort after medication, please go to see your doctor and receive timely medical treatment.

If you want to report a side effect or quality complaint, please contact your health care professional (e.g. treating physician or pharmacist) or your local health authority, Inquiries can also be directed to:

If you observe adverse event after Bayer Animal Health product application, you can transfer the information to us directly by:

To ask other question about Bayer China, please send e-mail to .

Bayer China
Bayer is a globalized innovation company with core competencies in the fields of health care and agriculture. Bayer develops new molecules for use in innovative products and solutions to improve the health of humans, animals and plants. Its research and development activities are based on a profound understanding of the biochemical processes in living organisms. Through its products, Bayer is contributing to finding solutions to some of the major challenges of our time. The growing and increasingly aging world population requires improved medical care and an adequate supply of food. Bayer is improving people’s quality of life by preventing, alleviating and curing diseases and the company is helping provide a reliable supply of high-quality food, feed and plant-based raw materials.
Bayer’s links with China have a long tradition, going back to 1882 when the company first came to China. With the country now among the fastest-growing markets in the world, Bayer has stepped up its involvement in the region. Today, Greater China (Mainland, Hong Kong, Taiwan) is Bayer's largest single market in Asia. By the end of 2017, about 10,000 people were employed by Bayer in Greater China.
Bayer is represented in Greater China by its three business divisions: Pharmaceuticals, Consumer Health and Crop Science, and operates several production facilities. Bayer started producing Aspirin in Shanghai as early as 1936, and now local production accounts for an increasing proportion of sales in Greater China. With a number of major investments under way, Bayer is positioned to be one of engines in China’s development.
Follow Us
Last updated:2019-01-31
Bayer China -Bayer China

Seite verkleinern Normalansicht Seite vergrößern

Bayer China

Bayer's links with China go back to 1882, when the company first began marketing dyes on the Chinese market. Bayer's interests in this exciting region(Mainland, Hong Kong, Taiwan) have grown steadily over the years, from step-by-step investment in the early 1990s to large-scale, world-class facilities today. With the commitment of "Bayer's Solution for China's Needs", Greater China has now become Bayer's largest single market in Asia, with sales of around EUR 2.9 billion in 2010. Currently around 11,000 people work for Bayer in Greater China, which is also among the major focuses of the company’s global investment.

The core strategy for Bayer in China is to grow in step with China's economic and social development. Close communicationwiththe government provides Bayer with a sound understanding of the local market's needs. In the 12th Five-Year Plan, the Chinese governmentaddressedcurrentchallenges, includingagriculturalproblems, energyscarcity, publichealth, and environmental pollution. Andwiththemain focus on sustainable development, the government will rollout reinforced solutions for these challenges. Bayer works under the principle "Science for a Better Life" and interprets it in China as “Bayer's solution for China's Needs”.

Bayer is represented in Greater China by its Bayer HealthCare, Bayer CropScience and Bayer MaterialScience subgroups and the service company Bayer Technology Services, and operates several production facilities there. Local production now accounts for an increasing proportion of sales in Greater China. With a number of major investments under way, Bayer is positioned to remain a key partner in China’s development.
  • Share to:
Follow Us